连续流左心室辅助装置植入时同期处理主动脉瓣反流可改善生存
基于日本注册数据库的回顾性研究纳入300例存在轻度及以上主动脉瓣反流(AR)的连续流左心室辅助装置(LVAD)接受者,比较同期AR手术(n=77)与未手术(n=223)的预后。校正AR后显著AR累积发生率更低(p<0.05);匹配队列中未校正AR者死亡率更高(p=0.052)。年龄≥57岁患者校正AR有生存改善趋势(p=0.099),<57岁者无差异(p=0.956)。
要点
- LVAD植入时同期校正AR可降低显著AR累积发生率(p<0.05)。
- 匹配队列中未校正AR者死亡率更高(p=0.052)。
- ≥57岁患者校正AR有生存改善趋势(p=0.099),<57岁无差异(p=0.956)。
核心结论
- 在年龄≥57岁的患者中,校正既存AR(包括轻度AR)可能改善LVAD植入后的长期生存。
研究设计与样本
- 回顾性研究,使用日本注册数据库,纳入300例连续流LVAD接受者且术前存在轻度及以上AR。
- 患者分为同期AR手术组(n=77)和未手术组(n=223),并进行倾向性评分匹配队列分析。
主要发现
- 校正AR后显著AR累积发生率在匹配前和匹配分析中均低于未校正AR(p<0.05)。
- 匹配前队列中两组死亡率和再入院率相似,匹配队列中未校正AR者死亡率更高(p=0.052)。
- 年龄≥57岁患者校正AR有生存改善趋势(p=0.099),<57岁患者差异可忽略(p=0.956)。
- 植入时轻度AR患者中,未校正AR显著AR风险增加(p=0.058),老年校正AR生存改善(p=0.054),年轻无生存差异(p=0.492)。
临床怎么用
- 对于年龄≥57岁、计划植入连续流LVAD且存在轻度及以上AR的患者,可考虑同期行AR校正手术以改善长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite the detrimental consequences associated with residual, progressive aortic regurgitation (AR) during LVAD support, correction of AR at LVAD implantation has rarely been shown to improve survival. METHODS: A retrospective study was conducted using the Japanese registry database, which included 300 continuous-flow LVAD recipients with pre-existing AR (mild or greater). Patients were divided into two groups: those who underwent concomitant surgery for AR during LVAD implantation (n = 77) and those who did not (n = 223). The groups were compared for significant AR development, all-cause mortality, and readmission for adverse events. A propensity score-matched cohort was also created to allow comparison of these outcomes to those of patients with similar baseline. RESULTS: The cumulative incidence of significant AR was lower after corrected AR than after uncorrected AR in both the pre-matched and matched analyses (p < 0.05). While mortality and readmission rates were similar between groups in the pre-matched cohort, mortality after uncorrected AR was higher in the matched cohort (p = 0.052). When the pre-matched cohort was divided by age, a trend towards improved survival (p = 0.099) was observed with correction compared to no correction in older patients (≥57 years), whereas the difference was negligible (p = 0.956) in younger patients (<57 years). These results were consistent in patients with mild AR at implantation, including the increased risk of significant AR for uncorrected AR (p = 0.058), as well as improved survival with AR correction in the older population (p = 0.054), but no survival difference in the younger population (p = 0.492). CONCLUSIONS: In older patients, correction of pre-existing AR, including mild AR, may improve long-term survival after LVAD implantation.
引用
- Kohno H, Matsumiya G, Saiki Y, et al. Improved survival with concomitant surgery for aortic regurgitation during continuous-flow left ventricular assist device implantation. Eur J Cardiothorac Surg. 2026. PMID: 41581213. doi:10.1093/ejcts/ezag052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。